Stents

Abbott, Absorb bioresorbable stent, dissolving, UAB, University of Alabama at Birmingham, first in state
News | Stents Bioresorbable | July 26, 2016
July 26, 2016 — On July 20, Massoud Leesar, M.D., of University of Alabama at Birmingham Hospital implanted a patient...
Absorb, bioresorbable stent, BVS

The Abbott Absorb stent gained FDA clearance in July 2016. It has metallic markers at each end so it can be visualized for proper positioning under angiographic X-ray imaging. 

Feature | Stents Bioresorbable | July 21, 2016 | Alphonse Ambrosia, D.O.
Some have labeled bioresorbable scaffolds (BRS), also known as bioresorbable stents, as the fourth evolution of...
Abbott Absorb bioresorbable stent, dissolving BVS, first West Coast implant, Good Samaritan Hospital Los Angeles
News | Stents Bioresorbable | July 19, 2016
July 19, 2016 — Good Samaritan Hospital, Los Angeles, is the first hospital on the West Coast to offer patients with...
Abbott, Absorb bioresorbable stent, University Hospitals Case Medical Center, first Midwest implant
News | Stents Bioresorbable | July 11, 2016
July 11, 2016 — University Hospitals Case Medical Center, Cleveland, is among the first in the country – and the first...
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, dissolving stent

The Abbott Absorb is the first bioresorbable stent to be cleared for use in the United States. 

Technology | Stents Bioresorbable | July 05, 2016 | Dave Fornell
July 5, 2016 — The U.S. Food and Drug Administration (FDA) has cleared the first fully bioresorbable coronary stent for...
Intact Vascular, TOBA III clinical study, Europe, Tack Endovascular System, peripheral artery disease, PAD
News | Peripheral Arterial Disease (PAD) | June 07, 2016
June 7, 2016 — Intact Vascular Inc. announced that its Tack Optimized Balloon Angioplasty III (TOBA III)...
News | Stents Bioresorbable | June 06, 2016
June 6, 2016 — Amaranth Medical announced that it completed enrollment in May in the RENASCENT-II study of its novel...
Biotronik, ORIENT trial results, EuroPCR 2016, Orsiro DES, hybrid drug-eluting stent
News | Stents Drug Eluting | June 03, 2016
June 3, 2016 — Biotronik announced results establishing non-inferiority of the Orsiro hybrid...
congenital heart, pulmonary artery stenting, JACC study
News | Congenital Heart | May 31, 2016
May 31, 2016 — In a recent study, the use of a ...
Biotronik, Magmaris bioresorbable magnesium scaffold, BIOSOLVE-II Trial, 12-month results, EuroPCR 2016
News | Stents Bioresorbable | May 17, 2016
May 17, 2016 — Biotronik presented 12-month data from the BIOSOLVE-II trial during a Hotline Session at EuroPCR 2016....

Biosensors' Biomatrix stent.

Feature | Stents | May 16, 2016
May 16, 2016 — Cardinal Health announced it has entered into a distribution agreement with Biosensors that enables...
TOBA-BTK study, twelve-month results, SCAI 2016, Tack Endovascular System, critical limb ischemia
News | Peripheral Arterial Disease (PAD) | May 05, 2016
May 5, 2016 — Intact Vascular Inc. announced that positive twelve-month results from its Tack Optimized Balloon...
Technology | Stents Peripheral | April 27, 2016
April 27, 2016 — Veniti Inc. announced the first successful treatment with the Vici Verto Venous Stent System of a...
Medtronic, Drug-Filled Stent, RevElution Trial results, ACC.16, CE Mark
News | Stents Drug Eluting | April 21, 2016
April 21, 2016 — Medtronic plc announced new clinical data from one of the endpoints in the RevElution Trial for its...
STEMI, delayed or deferred stent implantation, DANAMI-3-DEFER trial, ACC.16
News | Cath Lab | April 18, 2016
April 18, 2016 — Delayed or deferred stent...
Overlay Init